Next generation Limited-Angle time-of-flight PET imager
The PetVision project aims to develop a cost-effective, modular PET imaging device with enhanced sensitivity to improve cancer diagnostics accessibility across various medical settings.
Projectdetails
Introduction
Over 2.7 million people in the EU were diagnosed with cancer in 2020, while 1.3 million people lost their lives to it. Cancer cases are predicted to increase by 24% by 2035, making it the leading cause of death in the EU.
Current Diagnostic Techniques
The current leading specific molecular imaging diagnostic technique sensitive to cancer is based on Positron Emission Tomography (PET). Due to the high implementation cost of PET, this high-sensitivity diagnostics is only available to less than 0.5% of the medical centers in the world.
Cost Factors
The critical component of the overall cost is the cost of PET scanners.
Project Vision
Our project proposes a radical vision to translate European breakthrough technological advances in Time-of-Flight PET detection to a revolutionary, fully modular, cost-accessible flexible family of devices for applications including:
- Standard PET centers
- Surgery
- Epilepsy clinics
- Intensive care units
- Emergency rooms
- Mobile units installed in vans
Project Goals
The proposed PetVision project aims to develop a simple pilot demonstrator, a modular panel PET device with a coincidence timing resolution of about 75 ps FWHM, close to the intrinsic timing limit of currently available PET scintillators.
Performance Comparison
This resolution is several times better than the current gold standard of 214 ps FWHM achieved with the current clinical state-of-the-art device (Siemens Biograph Vision). With such excellent timing, the panel detectors can cover only a limited solid angle to reach the same sensitivity or improve the sensitivity in the case of a total-body imager.
Innovations
For the realization of the device, a package of breakthrough innovations in detector design, photo-sensor, and front-end electronics are planned.
Expected Impact
We expect that the proposed device will dramatically impact human health.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 3.374.041 |
Totale projectbegroting | € 3.374.041 |
Tijdlijn
Startdatum | 1-9-2023 |
Einddatum | 31-8-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- INSTITUT JOZEF STEFANpenvoerder
- FONDAZIONE BRUNO KESSLER
- UNIVERSITAT DE BARCELONA
- GENERAL EQUIPMENT FOR MEDICAL IMAGING SA
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
- KLINIKUM DER TECHNISCHEN UNIVERSITÄT MÜNCHEN (TUM KLINIKUM)
- THE GENERAL HOSPITAL CORPORATION
- YALE UNIVERSITY
- ORGANISATION EUROPEENNE POUR LA RECHERCHE NUCLEAIRE
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancyThe PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance. | EIC Pathfinder | € 2.982.792 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Smart Electronic Olfaction for Body Odor DiagnosticsSMELLODI aims to digitize and synthesize olfactory information for remote disease diagnostics and assist individuals with olfactory disorders using advanced sensor technology and machine learning. | EIC Pathfinder | € 3.263.781 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy
The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Smart Electronic Olfaction for Body Odor Diagnostics
SMELLODI aims to digitize and synthesize olfactory information for remote disease diagnostics and assist individuals with olfactory disorders using advanced sensor technology and machine learning.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
CHerenkov Light mOdulE for time-of-flight Positron Emission TomographyThe CHLOE-PET project aims to develop an advanced gamma detector for TOF-PET that enhances time and spatial resolution by up to 7 and 10 times, improving cancer diagnostics without extra costs. | ERC STG | € 1.384.755 | 2023 | Details |
Open Geometry PET, with 150ps TOF Resolution, for Real Time Molecular ImagingOpen-IMAGING aims to create a flexible Open Imaging System using advanced PET technology for high-resolution imaging, enabling safer interventions and improved patient monitoring. | ERC POC | € 150.000 | 2022 | Details |
Cherenkov light for total-body Positron Emission TomographyThe project aims to develop a cost-effective, high-performance PET scanner using Cherenkov photon detection to enhance early cancer diagnosis and treatment monitoring. | ERC POC | € 150.000 | 2023 | Details |
In vivo Immunofluorescence-Optical Coherence TomographyDevelop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease. | ERC ADG | € 2.500.000 | 2025 | Details |
CHerenkov Light mOdulE for time-of-flight Positron Emission Tomography
The CHLOE-PET project aims to develop an advanced gamma detector for TOF-PET that enhances time and spatial resolution by up to 7 and 10 times, improving cancer diagnostics without extra costs.
Open Geometry PET, with 150ps TOF Resolution, for Real Time Molecular Imaging
Open-IMAGING aims to create a flexible Open Imaging System using advanced PET technology for high-resolution imaging, enabling safer interventions and improved patient monitoring.
Cherenkov light for total-body Positron Emission Tomography
The project aims to develop a cost-effective, high-performance PET scanner using Cherenkov photon detection to enhance early cancer diagnosis and treatment monitoring.
In vivo Immunofluorescence-Optical Coherence Tomography
Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.